Patent · US Active

Compositions and methods for delivery of genetic material

US8304234B2 · kind B2 · utility

3Cited by
14References
28Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 23, 2005
Grant dateNov 6, 2012
Priority date
Expiry dateAug 16, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of introducing genetic material into cells of an individual and compositions and kits for practicing the same are disclosed. The methods comprise the steps of contacting cells of an individual with a polynucleotide function enhancer and administering to the cells, a nucleic acid molecule that is free of retroviral particles. The nucleic acid molecule comprises a nucleotide sequence that encodes a protein that comprises at least one epitope that is identical or substantially similar to an epitope of a pathogen antigen or an antigen associated with a hyperproliferative or autoimmune disease, a protein otherwise missing from the individual due to a missing, non-functional or partially functioning gene, or a protein that produces a therapeutic effect on an individual. Methods of prophylactically and therapeutically immunizing an individual against HIV am disclosed. Pharmaceutical compositions and kits for practicing methods of the present invention are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.